Effect of nitric oxide synthesis inhibition with nebulized L-NAME on ventilation-perfusion distributions in bronchial asthma

European Respiratory Journal

Volumn 12, Issue 4, 1998, Pages 865-871

  Gomez F P ^a   Barbera J A ^a,c   Roca, J ^a   Iglesia, R ^a   Ribas, J ^a   Barnes, P J ^b   Rodriguez Roisin, R ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Arginine analogues; Nitric oxide synthase inhibitors; Pulmonary catheterization; Pulmonary gas exchange

Indexed keywords

N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; EXPIRED AIR; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG GAS EXCHANGE; LUNG VENTILATION PERFUSION RATIO; MALE; NEBULIZATION; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

ADMINISTRATION, INHALATION; ADULT; AIRWAY RESISTANCE; ASTHMA; CROSS-OVER STUDIES; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PULMONARY GAS EXCHANGE; REFERENCE VALUES; VENTILATION-PERFUSION RATIO;

EID: 0031723220     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12040865     Document Type: Article

References (35)

1. Rodriguez-Roisin R, Ferrer A, Navajas D, Agustí AGN, Wagner PD, Roca J. Ventilation-perfusion mismatch after methacholine challenge in patients with mild bronchial asthma. Am Rev Respir Dis 1991; 144: 88-94.
2. Roca J, Ramis LI, Rodriguez-Roisin R, Ballester E, Montserrat JM, Wagner PD. Serial relationships between V′A/Q′ inequality and spirometry in acute severe asthma requiring hospitalization. Am Rev Respir Dis 1988; 137: 605-612.
3. Wagner PD, Hedenstierna G, Rodriguez-Roisin R. Gas exchange, expiratory flow obstruction and the clinical spectrum of asthma. Eur Respir J 1996; 9: 1278-1282.
4. Kobzik L, Brendt DS, Lowenstein CJ, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993; 9: 371-377.
5. Barnes PJ, Belvisi MG. Nitric oxide and lung disease. Thorax 1993; 48: 1034-1043.
6. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6: 1368-1370.
7. Persson MG, Zetterström O, Argenius V, Ihre E, Gustafsson LE. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994; 343: 146-147.
8. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-135.
9. Yates DH, Kharitonov SA, Thomas PS, Barnes PJ. Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am J Respir Crit Care Med 1996; 154: 247-250.
10. Barnes PJ. NO or not NO in asthma. Thorax 1996; 51: 218-220.
11. Högman MM, Frostell CG, Hedenström H, Hedenstierna G. Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis 1993; 148: 1474-1478.
12. de Gow HWFM, Grünberg K, Schot R, Kroes ACM, Dick EC, Sterk PJ. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur Respir 1988; 11: 126-132.
13. Charan NB, Johnson SR, Lakshminarayan S, Thompson WH, Carvalho P. Nitric oxide and β-adrenergic agonist-induced bronchial arterial vasodilation. J Appl Physiol 1997; 82: 686-692.
14. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapoi WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 1993; 78: 427-435.
15. Rodriguez-Roisin R, Roca J. Contribution of multiple inert gas elimination technique to pulmonary medicine -3: bronchial asthma. Thorax 1994; 49: 1027-1033.
16. Barberà JA, Roger N, Roca J, Rovira I, Higenbottam TW, Rodriguez-Roisin R. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet 1996; 347: 436-440.
17. Yates DH, Kharitonov SA, Robbins RA, Thomas PS, Barnes PJ. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995; 152: 892-896.
18. Gómez FP, Martínez-Pallì G, Barberà JA, Roca J, Rodríguez-Roisin R. Medicíon de óxido nítrico exhalado en sujetos sanos. Med Clin (Barc) 1998; 111: 1-5.
19. Cardús J, Burgos F, Diaz O, et al. Increase in pulmonary ventilation-perfusion inequality with age in healthy individuals. Am J Respir Crit Care Med 1997; 156: 648-653.
20. Farré R, Peslin R, Rotger M, Navajas D. Human lung impedance from spontaneous breathing frequencies to 32 Hz. J Appl Physiol 1994; 76: 1176-1183.
21. Roca J, Wagner PD. Contribution of multiple inert gas elimination technique to pulmonary medicine - 1: principles and information content of the multiple inert gas elimination technique. Thorax 1994; 49: 815-824.
22. Kharitonov SA, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. Eur Respir J 1997; 10: 1683-1693.
23. Kharitonov SA, Wells AU, O'Connor BJ, et al. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med 1995; 151: 1889-1893.
24. Kharitonov SA, O'Connor BJ, Evans DJ, Barnes PJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 1995; 151: 1894-1899.
25. Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, Drazen JM. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995; 152: 800-803.
26. Barnes PJ, Kharitonov SA. Exhaled nitric oxide: a new lung function test. Thorax 1996; 51: 233-237.
27. Ballester E, Roca J, Rodriguez-Roisin R, Agusti-Vidal A. Effect of nifedipine on arterial hypoxemia occurring after methacholine challenge in asthma. Thorax 1986; 41: 468-472.
28. Ballester E, Roca J, Ramis L, Wagner PD, Rodriguez-Roisin R. Pulmonary gas exchange in severe chronic asthma. Response to 100% oxygen and salbutamol. Am Rev Respir Dis 1990; 141: 558-562.
29. Greenberg B, Kishiyama S. Endothelium-dependent and -independent responses to severe hypoxia in rat pulmonary artery. Am J Physiol 1993; 265: H1712-H1720.
30. Teng GQ, Barer GR. In vitro responses of lung arteries to acute hypoxia after NO synthase blockade or chronic hypoxia. J Appl Physiol 1995; 79: 763-770.
31. Putensen C, Räsänen J, Downs JB. Effect of endogenous and inhaled nitric oxide on the ventilation-perfusion relationships in oleic-acid lung injury. Am J Respir Crit Care Med 1994; 150: 330-336.
32. Sprague RS, Thiemermann C, Vane RJ. Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits. Proc Natl Acad Sci USA 1992; 89: 8711-8715.
33. Ricciardolo FL, Geppetti P, Mistretta A, et al. Randomized double-blind placebo controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma. Lancet 1996; 348: 374-377.
34. Brain JD, Blanchard JD. Deposition and fate of inhaled pharmacological aerosols. In: Spector SL, ed. Provocation Testing in Clinical Practice. New York, Marcel Dekker, 1995; pp. 157-214.
35. Persson MG, Gustafsson LE, Wiklund NP, Moncada S, Hedqvist P. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. Acta Physiol Scand 1990; 140: 449-457.